Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sally E. Blount currently holds 35,023 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sally E. Blount has been a net seller of ABT stock. They have purchased $248.4K and sold $332.3K worth of shares.
Sally E. Blount's most recent insider trade was on Apr 26, 2024, when they sold 1,866 shares at $0.00 per share.
Sally E. Blount serves as Executive at ABBOTT LABORATORIES (ABT). They have executed 20 insider transactions totaling $580.7K over their tenure at the company.
Sally E. Blount holds the position of Executive at ABBOTT LABORATORIES, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Sally E. Blount has shown a selling trading pattern, with $248.4K in total purchases and $332.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sally E. Blount was on Jul 31, 2019, when they sold $219.1K worth of ABT shares. This transaction involved 2,500 shares at $87.65 per share.
Sally E. Blount currently owns 35,023 shares of ABBOTT LABORATORIES (ABT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sally E. Blount's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sally E. Blount has 20 Form 4 filings on record as an insider at ABBOTT LABORATORIES.
Set alerts for Sally E. Blount and 40,000+ other insiders.